Cargando…

The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis

BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, Ludmila T., Costa, Deiziane V. S., Gomes, Antoniella S., Martins, Conceição S., Silva, Angeline M. H. P., Coelho-Aguiar, Juliana M., Castelucci, Patrícia, Lima-Júnior, Roberto C. P., Leitão, Renata F. C., Moura-Neto, Vivaldo, Brito, Gerly A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384042/
https://www.ncbi.nlm.nih.gov/pubmed/28388962
http://dx.doi.org/10.1186/s12974-017-0854-1
_version_ 1782520391702413312
author Nogueira, Ludmila T.
Costa, Deiziane V. S.
Gomes, Antoniella S.
Martins, Conceição S.
Silva, Angeline M. H. P.
Coelho-Aguiar, Juliana M.
Castelucci, Patrícia
Lima-Júnior, Roberto C. P.
Leitão, Renata F. C.
Moura-Neto, Vivaldo
Brito, Gerly A. C.
author_facet Nogueira, Ludmila T.
Costa, Deiziane V. S.
Gomes, Antoniella S.
Martins, Conceição S.
Silva, Angeline M. H. P.
Coelho-Aguiar, Juliana M.
Castelucci, Patrícia
Lima-Júnior, Roberto C. P.
Leitão, Renata F. C.
Moura-Neto, Vivaldo
Brito, Gerly A. C.
author_sort Nogueira, Ludmila T.
collection PubMed
description BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whether CPT-11 is able to alter the enteric glial and neuronal cell, and the role of mast cells in this effect. Therefore, this study was conducted to investigate the effect of CPT-11 on the enteric glial and neuronal cells, as well as to study the role of mast cells in the CPT-11-induced intestinal mucositis. METHODS: Intestinal mucositis was induced in Swiss mice by the injection of CPT-11 (60 mg/kg, i.p.) once a day for 4 days following by euthanasia on the fifth day. To investigate the role of mast cells, the mice were pretreated with compound 48/80 for 4 days (first day, 0.6 mg/kg; second day, 1.0 mg/kg; third day, 1.2 mg/kg; fourth day, 2.4 mg/kg) to induce mast cell degranulation before the CPT-11 treatment. RESULTS: Here, we show that CPT-11 increased glial fibrillary acidic protein (GFAP) and S100β gene and S100β protein expressions and decreased HuC/D protein expression in the small intestine segments. Concomitantly, CPT-11 enhanced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels and inducible nitric oxide synthase (iNOS) gene expression, associated with an increase in the total number macrophages (positive cells for ionized calcium-binding adapter molecule, Iba-1) and degranulated mast cells in the small intestine segments and caused significant weight loss. The pretreatment with compound 48/80, an inductor of mast cells degranulation, significantly prevented these CPT-11-induced effects. CONCLUSIONS: Our data suggests the participation of mast cells on the CPT-11-induced intestinal mucositis, macrophages activation, enteric reactive gliosis, and neuron loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0854-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5384042
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53840422017-04-12 The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis Nogueira, Ludmila T. Costa, Deiziane V. S. Gomes, Antoniella S. Martins, Conceição S. Silva, Angeline M. H. P. Coelho-Aguiar, Juliana M. Castelucci, Patrícia Lima-Júnior, Roberto C. P. Leitão, Renata F. C. Moura-Neto, Vivaldo Brito, Gerly A. C. J Neuroinflammation Research BACKGROUND: The irinotecan (CPT-11) causes intestinal mucositis and diarrhea that may be related to changes in the enteric nervous system (ENS). In inflammatory condition, mast cells release a variety of pro-inflammatory mediators that can interact with the ENS cells. It has not been explored whether CPT-11 is able to alter the enteric glial and neuronal cell, and the role of mast cells in this effect. Therefore, this study was conducted to investigate the effect of CPT-11 on the enteric glial and neuronal cells, as well as to study the role of mast cells in the CPT-11-induced intestinal mucositis. METHODS: Intestinal mucositis was induced in Swiss mice by the injection of CPT-11 (60 mg/kg, i.p.) once a day for 4 days following by euthanasia on the fifth day. To investigate the role of mast cells, the mice were pretreated with compound 48/80 for 4 days (first day, 0.6 mg/kg; second day, 1.0 mg/kg; third day, 1.2 mg/kg; fourth day, 2.4 mg/kg) to induce mast cell degranulation before the CPT-11 treatment. RESULTS: Here, we show that CPT-11 increased glial fibrillary acidic protein (GFAP) and S100β gene and S100β protein expressions and decreased HuC/D protein expression in the small intestine segments. Concomitantly, CPT-11 enhanced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels and inducible nitric oxide synthase (iNOS) gene expression, associated with an increase in the total number macrophages (positive cells for ionized calcium-binding adapter molecule, Iba-1) and degranulated mast cells in the small intestine segments and caused significant weight loss. The pretreatment with compound 48/80, an inductor of mast cells degranulation, significantly prevented these CPT-11-induced effects. CONCLUSIONS: Our data suggests the participation of mast cells on the CPT-11-induced intestinal mucositis, macrophages activation, enteric reactive gliosis, and neuron loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0854-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-07 /pmc/articles/PMC5384042/ /pubmed/28388962 http://dx.doi.org/10.1186/s12974-017-0854-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nogueira, Ludmila T.
Costa, Deiziane V. S.
Gomes, Antoniella S.
Martins, Conceição S.
Silva, Angeline M. H. P.
Coelho-Aguiar, Juliana M.
Castelucci, Patrícia
Lima-Júnior, Roberto C. P.
Leitão, Renata F. C.
Moura-Neto, Vivaldo
Brito, Gerly A. C.
The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title_full The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title_fullStr The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title_full_unstemmed The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title_short The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
title_sort involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384042/
https://www.ncbi.nlm.nih.gov/pubmed/28388962
http://dx.doi.org/10.1186/s12974-017-0854-1
work_keys_str_mv AT nogueiraludmilat theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT costadeizianevs theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT gomesantoniellas theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT martinsconceicaos theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT silvaangelinemhp theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT coelhoaguiarjulianam theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT casteluccipatricia theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT limajuniorrobertocp theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT leitaorenatafc theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT mouranetovivaldo theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT britogerlyac theinvolvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT nogueiraludmilat involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT costadeizianevs involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT gomesantoniellas involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT martinsconceicaos involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT silvaangelinemhp involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT coelhoaguiarjulianam involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT casteluccipatricia involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT limajuniorrobertocp involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT leitaorenatafc involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT mouranetovivaldo involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis
AT britogerlyac involvementofmastcellsintheirinotecaninducedentericneuronslossandreactivegliosis